| Immune landscape of viral-and carcinogen-driven head and neck cancer AR Cillo, CHL Kürten, T Tabib, Z Qi, S Onkar, T Wang, A Liu, U Duvvuri, ... Immunity 52 (1), 183-199. e9, 2020 | 453 | 2020 |
| Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy AR Cillo, MD Sobolewski, RJ Bosch, E Fyne, M Piatak Jr, JM Coffin, ... Proceedings of the National Academy of Sciences 111 (19), 7078-7083, 2014 | 267 | 2014 |
| B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma AT Ruffin, AR Cillo, T Tabib, A Liu, S Onkar, SR Kunning, C Lampenfeld, ... Nature communications 12 (1), 3349, 2021 | 177 | 2021 |
| Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer AE Overacre-Delgoffe, HJ Bumgarner, AR Cillo, AHP Burr, JT Tometich, ... Immunity 54 (12), 2812-2824. e4, 2021 | 148 | 2021 |
| Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART A Wiegand, J Spindler, FF Hong, W Shao, JC Cyktor, AR Cillo, EK Halvas, ... Proceedings of the National Academy of Sciences 114 (18), E3659-E3668, 2017 | 145 | 2017 |
| Improved single-copy assays for quantification of persistent HIV-1 viremia in patients on suppressive antiretroviral therapy AR Cillo, D Vagratian, MA Bedison, EM Anderson, MF Kearney, E Fyne, ... Journal of clinical microbiology 52 (11), 3944-3951, 2014 | 129 | 2014 |
| Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing CHL Kürten, A Kulkarni, AR Cillo, PM Santos, AK Roble, S Onkar, ... Nature communications 12 (1), 7338, 2021 | 126 | 2021 |
| COVID-19 versus non–COVID-19 acute respiratory distress syndrome: comparison of demographics, physiologic parameters, inflammatory biomarkers, and clinical outcomes W Bain, H Yang, FA Shah, T Suber, C Drohan, N Al-Yousif, RS DeSensi, ... Annals of the American Thoracic Society 18 (7), 1202-1210, 2021 | 124 | 2021 |
| Novel assays for measurement of total cell-associated HIV-1 DNA and RNA F Hong, E Aga, AR Cillo, AL Yates, G Besson, E Fyne, DL Koontz, ... Journal of clinical microbiology 54 (4), 902-911, 2016 | 109 | 2016 |
| Intractable coronavirus disease 2019 (COVID-19) and prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in a chimeric antigen receptor-modified T … MK Hensley, WG Bain, J Jacobs, S Nambulli, U Parikh, A Cillo, B Staines, ... Clinical Infectious Diseases 73 (3), e815-e821, 2021 | 96 | 2021 |
| Plasma viremia and cellular HIV-1 DNA persist despite autologous hematopoietic stem cell transplantation for HIV-related lymphoma AR Cillo, A Krishnan, RT Mitsuyasu, DK McMahon, S Li, JJ Rossi, JA Zaia, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 63 (4), 438-441, 2013 | 80 | 2013 |
| A Bayesian mixture model for clustering droplet-based single-cell transcriptomic data from population studies Z Sun, L Chen, H Xin, Y Jiang, Q Huang, AR Cillo, T Tabib, JK Kolls, ... Nature communications 10 (1), 1649, 2019 | 70 | 2019 |
| Three distinct phases of HIV-1 RNA decay in treatment-naive patients receiving raltegravir-based antiretroviral therapy: ACTG A5248 A Andrade, SL Rosenkranz, AR Cillo, D Lu, ES Daar, JM Jacobson, ... The Journal of infectious diseases 208 (6), 884-891, 2013 | 67 | 2013 |
| Which therapeutic strategy will achieve a cure for HIV-1? AR Cillo, JW Mellors Current opinion in virology 18, 14-19, 2016 | 66 | 2016 |
| Autoreactive CD8+ T cells are restrained by an exhaustion-like program that is maintained by LAG3 S Grebinoski, Q Zhang, AR Cillo, S Manne, H Xiao, EA Brunazzi, T Tabib, ... Nature immunology 23 (6), 868-877, 2022 | 56 | 2022 |
| Molecular pathways and mechanisms of LAG3 in cancer therapy LP Andrews, AR Cillo, L Karapetyan, JM Kirkwood, CJ Workman, ... Clinical Cancer Research 28 (23), 5030-5039, 2022 | 53 | 2022 |
| Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding LP Andrews, A Somasundaram, JM Moskovitz, AL Szymczak-Workman, ... Science immunology 5 (49), eabc2728, 2020 | 45 | 2020 |
| Intractable COVID-19 and prolonged SARS-CoV-2 replication in a CAR-T-cell therapy recipient: a case study MK Hensley, WG Bain, J Jacobs, S Nambulli, U Parikh, A Cillo, B Staines, ... Clin Infect Dis 73 (3), e815-e821, 2021 | 39 | 2021 |
| New tools for quantifying HIV-1 reservoirs: plasma RNA single copy assays and beyond BB Hilldorfer, AR Cillo, GJ Besson, MA Bedison, JW Mellors Current HIV/AIDS Reports 9, 91-100, 2012 | 38 | 2012 |
| Impact of chemotherapy for HIV-1 related lymphoma on residual viremia and cellular HIV-1 DNA in patients on suppressive antiretroviral therapy AR Cillo, S Krishnan, DK McMahon, RT Mitsuyasu, MF Para, JW Mellors PLoS One 9 (3), e92118, 2014 | 30 | 2014 |
